Home > Insider Trading > Filing (0000899866-15-000212)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
899866	Alexion Pharmaceuticals Inc	ALXN	Pharmaceutical Preparations (2834)	133648318

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1231949	Leonard Bell	C/O Alexion Pharmaceuticals Inc 352 Knotter Drive Cheshire CT 06410		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $.0001 Per Share	Disposition	2015-12-11	42,637	$0.00	806,451	No	4	G	Direct
Common Stock, Par Value $.0001 Per Share	Disposition	2015-12-11	22,597	$0.00	783,854	No	4	G	Direct
Common Stock, Par Value $.0001 Per Share	Disposition	2015-12-11	34,595	$0.00	749,259	No	4	G	Direct
Common Stock	Disposition	2015-12-11	16,967	$187.41	732,292	No	4	S	Indirect	By trust
Common Stock	Disposition	2015-12-11	4,352	$188.13	727,940	No	4	S	Indirect	By trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	G	Direct
No	4	G	Direct
No	4	G	Direct
No	4	S	Indirect	By trust
No	4	S	Indirect	By trust

Footnotes

The reporting person contributed 42,637 shares of Alexion common stock to a charitable remainder trust. The reporting person continues to report beneficial ownership of all of the Alexion common stock held by the trust.
Gift to charitable fund.
Gift to charitable foundation.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $187.01 - $188.01. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $188.01 - $189.01. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.